Stay updated on Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The Locations section was added and now lists California, Florida, Georgia, Indiana, Maryland, Michigan, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, and Pennsylvania, with the revision tag updated to v3.3.3. Previous location subpages (e.g., California Locations, Florida Locations, etc.) were removed, and the HHS Vulnerability Disclosure link was removed.
    Difference
    1%
    Check dated 2025-12-23T17:15:30.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    A new revision label "Revision: v3.3.2" was added and the previous "Revision: v3.2.0" label was removed.
    Difference
    0.0%
    Check dated 2025-11-24T21:26:33.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The notice about government funding status was removed, a non-substantive banner that does not affect the study details, eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T18:52:26.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The new screenshot shows minor UI updates and small data refinements to the study record (e.g., updated dates/locations) while the core study design and outcome information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T13:19:27.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision.
    Difference
    2%
    Check dated 2025-10-06T04:13:53.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Removed a specific resource entry (Head and neck squamous cell carcinoma) and updated the page version to v3.1.0.
    Difference
    0.4%
    Check dated 2025-09-28T23:38:16.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.